IOVANCE BIOTHERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Iovance Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$102M, a 7.42% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$459M, a 7.21% decline year-over-year.
  • Iovance Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$461M, a 15.5% decline from 2022.
  • Iovance Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$399M, a 16.4% decline from 2021.
  • Iovance Biotherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$343M, a 30.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$459M -$102M +$8.17M +7.42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$467M -$118M -$6.87M -6.19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$461M -$121M -$14.2M -13.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$446M -$118M -$18M -17.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$428M -$110M -$10.4M -10.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$418M -$111M -$19.1M -20.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$399M -$107M -$7.57M -7.61% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$391M -$100M -$14.2M -16.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$377M -$99.7M -$18.3M -22.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$359M -$91.7M -$16.1M -21.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$343M -$99.5M -$30.9M -45.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$312M -$86.2M -$27.3M -46.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$284M -$81.4M -$17.8M -28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$267M -$75.6M -$4.76M -6.72% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$262M -$68.5M -$3.42M -5.26% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$259M -$59M -$7.36M -14.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$251M -$63.6M -$13.5M -26.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$238M -$70.8M -$30.8M -77.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$207M -$65.1M -$30.2M -86.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$177M -$51.6M -$16.6M -47.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$160M -$50.2M -$18.8M -59.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$141M -$40M -$13.1M -48.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$128M -$34.9M -$8.87M -34% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$119M -$35.1M -$12.7M -56.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$107M -$31.4M -$7.8M -33.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$98.9M -$26.9M -$6M -28.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$92.9M -$26.1M -$10.1M -63.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$82.7M -$22.3M -$3.36M -17.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$79.4M -$23.6M -$11.9M -101% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$67.5M -$20.9M -$13.9M -198% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$53.6M -$15.9M -$7.44M -87.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$46.2M -$19M -$11.3M -148% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$34.9M -$11.7M -$5.29M -82.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$29.6M -$7.01M -$1.71M -32.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$27.9M -$8.48M -$3.61M -74.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$24.2M -$7.64M -$4.84M -173% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$19.4M -$6.44M -$4.33M -205% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$15.1M -$5.3M -$3.04M -134% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$12M -$4.87M +$6.63M +57.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$18.7M -$2.8M +$6.61M +70.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$25.3M -$2.11M -$1.08M -105% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$24.2M -$2.26M -$1.55M -221% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q4 2013 -$22.6M -$11.5M -$9.78M -568% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$12.9M -$9.41M -$7.78M -478% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$5.08M -$1.03M +$617K +37.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$5.7M -$705K +$2.43M +77.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$8.13M -$1.72M +$2.46M +58.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$10.6M -$1.63M +$4.19M +72% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$14.8M -$1.65M +$8.91M +84.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-10-23
Q1 2012 -$23.7M -$3.14M -$2.48M -376% Jan 1, 2012 Mar 31, 2012 10-Q 2013-10-23
Q4 2011 -$21.2M -$4.18M Oct 1, 2011 Dec 31, 2011 10-K 2013-09-23
Q3 2011 -$5.81M -$5.65M -3381% Jul 1, 2011 Sep 30, 2011 10-Q 2013-01-25
Q2 2011 -$10.6M -$10.5M -12379% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-10
Q1 2011 -$658K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$167K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$84.6K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.